Internal Medicine, Endocrinology, Diabetes, & Metabolism · Newark, NJ
NPI
1093808164
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
268 Dr Martin Luther King Jr Blvd Ste B
Newark, NJ, 07102
Phone (973) 877-5185
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,665
114 services
Medicare patients, 2024
79
Average age 75
Drug cost, 2024
$1.2M
2,771 prescriptions
Company payments, 2025
$19.11
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas G Baranetsky was code 99214 (office e&m - established), 42 times for 36 patients. In total Nicholas G Baranetsky billed 114 services in 8 codes, and Medicare paid $7,665.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 42 | 36 | $77.77 | $3,266 |
| 99214 Office E&M - Established | Facility | 24 | 18 | $76.96 | $1,847 |
| 99213 Office E&M - Established | Facility | 14 | 12 | $46.70 | $654 |
By year: 2022 $34K for 449 services; 2023 $24K for 304 services; 2024 $7,665 for 114 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas G Baranetsky prescribed most often to Medicare patients was Levothyroxine Sodium, with 323 prescriptions and refills. In total Nicholas G Baranetsky wrote 2,771 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 323 | 915 | 99 | $3,670 |
| Metformin Hcl Generic | 210 | 524 | 68 | $1,616 |
| Ozempic Semaglutide | 161 | 301 | 42 | $273K |
| Atorvastatin Calcium Generic | 120 | 297 | 42 | $850 |
| Synthroid Levothyroxine Sodium | 104 | 271 | 29 | $8,537 |
| Farxiga Dapagliflozin Propanediol | 92 | 148 | 21 | $78K |
| Rosuvastatin Calcium Generic | 87 | 240 | 30 | $1,554 |
| Methimazole Generic | 84 | 199 | 25 | $992 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 58 | 143 | 22 | $13K |
| Mounjaro Tirzepatide | 55 | 73 | Under 11 | $72K |
| Rybelsus Semaglutide | 54 | 104 | 17 | $94K |
| Losartan Potassium Generic | 52 | 134 | 18 | $711 |
| Jardiance Empagliflozin | 50 | 90 | 18 | $50K |
| Glipizide Generic | 46 | 132 | 17 | $280 |
| Pravastatin Sodium Generic | 41 | 97 | 12 | $343 |
Brand drugs: 1,138 claims; generic drugs: 1,448 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas G Baranetsky $19.11 ($19.11 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $19.11.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $19.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.